⌘K

Login Start Free

Home/Filings/4/0001562180-23-001787

4//SEC Filing

IGUCHI KIMI 4

Accession 0001562180-23-001787

CIK 0001597553other

View on SEC.gov Company Profile

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 6:03 PM ET

Size

12.6 KB

Accession

0001562180-23-001787

Insider Transaction Report

Form 4

Period: 2023-02-21

Sage Therapeutics, Inc.SAGE

See Remarks

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2023-02-23−250→ 4,642 total
Exercise: $1.36Exp: 2024-01-22→ Common Stock (250 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2023-02-21−750→ 4,892 total
Exercise: $1.36Exp: 2024-01-22→ Common Stock (750 underlying)
Exercise/Conversion
Common Stock
2023-02-21$1.36/sh+750$1,020→ 62,310 total
Exercise/Conversion
Common Stock
2023-02-23$1.36/sh+250$340→ 62,560 total

Footnotes (1)

[F1]The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on July 23, 2016.

Documents

2 files

Issuer

Sage Therapeutics, Inc.

CIK 0001597553

Entity typeother

Related Parties

1

filerCIK 0001304815

Filing Metadata

Form type: 4
Filed: Feb 22, 7:00 PM ET
Accepted: Feb 23, 6:03 PM ET
Size: 12.6 KB

View on SEC.gov